You are here

  • Home
  • Archive
  • Volume 68, Issue 3
  • Letter in response to: Stark P et al Amoxycillin-clavulanate for chronic wet cough in children: cautious interpretation of study findings warranted

Article Text

Article menu

Download PDFPDF

PostScript
Correspondence
Letter in response to: Stark P et al Amoxycillin-clavulanate for chronic wet cough in children: cautious interpretation of study findings warranted
Free
  1. Julie Marchant1,
  2. Helen Petsky1,
  3. Anne B Chang1,2
  1. 1Queensland Children's Respiratory Centre, Royal Children's Hospital, Brisbane, Queensland, Australia
  2. 2Child Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia
  1. Correspondence to Dr Julie Marchant, Queensland Children's Respiratory Centre, Royal Children's Hospital, Brisbane, QLD 4029, Australia; j.marchant{at}uq.edu.au

https://doi.org/10.1136/thoraxjnl-2012-203059

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Stark and colleagues1 for comments on our paper and their interest in our recent randomised controlled trial (RCT) of amoxycillin-clavulanate compared with placebo for children with chronic wet cough,2 which as they state are a ‘group of patients that often present paediatricians with a management dilemma’ and which ‘represents a valuable contribution to the literature’. We feel it is important to clarify a few points raised.

    First, the criteria used for defining chronic cough in children (>3 weeks) was at the time of the study commencement the definition of chronic childhood cough. We acknowledge following the study completion (enrolment between …

    View Full Text

    Linked Articles